Skip to content
Screener

Lucid Diagnostics LUCD Q4 2025 Annual earnings

Reported March 25, 2026 · Before market open

Revenue$1.5MBeat by $141.1K
EPS-$0.10Miss by $0.03
Revenue estimate$1.4M
EPS estimate-$0.07

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$1.7M
EPS estimate-$0.04

Financials

Q4 2025

Income statement

See full
Revenue$1.5M+25.6%
Operating income-$14.0M-13.2%
Net income-$16.3M-40.9%

Balance sheet

See full
Cash & equivalents$34.7M+55.2%
Total debt$1.8M-31.4%
Total equity$10.9M+103%
Total assets$40.4M+31.7%

Cash flow

See full
Operating cash flow-$12.6M-27.4%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$142.9M+194%
Enterprise value$110.01M+281%
P/S30.4×+19.2×

Profitability

See full
Operating margin-1,054.8%-4.8pp
Net margin-1,232.7%+264pp

Returns & leverage

See full
Return on equity-710.6%—
Debt / equity0.2×-0.3×
Current ratio1.3×+0.2×

FAQ

When did Lucid Diagnostics report Q4 2025 earnings?
Lucid Diagnostics (LUCD) reported Q4 2025 earnings on March 25, 2026 before market open.
What were Lucid Diagnostics's Q4 2025 revenue and EPS?
Lucid Diagnostics reported revenue of $1.5M and eps of $-0.10 for Q4 2025.
Did Lucid Diagnostics beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.4M by $141.1K. EPS missed the consensus estimate of $-0.07 by $0.03.
How did Lucid Diagnostics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 25.6% from $1.2M a year earlier and eps grew 47.4% from $-0.19.
Where can I find Lucid Diagnostics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-012807) and the 10-K periodic report (0001437749-26-009805) directly on SEC EDGAR. The filing index links above go to sec.gov.